These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16308692

  • 1. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
    Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE.
    Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
    [Abstract] [Full Text] [Related]

  • 2. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE.
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
    Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, Neuwelt EA.
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
    [Abstract] [Full Text] [Related]

  • 4. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
    Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE.
    Eur Radiol; 2004 Oct; 14(10):1851-8. PubMed ID: 15249981
    [Abstract] [Full Text] [Related]

  • 5. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations.
    Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, Harms S, Weinreb J, Small W, Sukerkar A, Brown JJ, Zelch J, Lucas M, Morris M, Hahn PF.
    J Comput Assist Tomogr; 2001 Oct; 25(5):770-6. PubMed ID: 11584239
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T, Wolf G.
    Cancer Biomark; 2009 Oct; 5(2):69-73. PubMed ID: 19414923
    [Abstract] [Full Text] [Related]

  • 7. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
    Yancy AD, Olzinski AR, Hu TC, Lenhard SC, Aravindhan K, Gruver SM, Jacobs PM, Willette RN, Jucker BM.
    J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
    [Abstract] [Full Text] [Related]

  • 8. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM, Weishaupt D, Persohn E, Goepfert K, Froehlich J, Sasse B, Gottschalk J, Marincek B, Kaim AH.
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [Abstract] [Full Text] [Related]

  • 9. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging.
    Saini S, Sharma R, Baron RL, Turner DA, Ros PR, Hahn PF, Small WC, Delange EE, Stillman AE, Edelman RR, Runge VM, Outwater EK.
    Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047
    [Abstract] [Full Text] [Related]

  • 10. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
    Azoulay R, Olivier P, Baud O, Verney C, Santus R, Robert P, Gressens P, Sebag G.
    J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles.
    Brillet PY, Gazeau F, Luciani A, Bessoud B, Cuénod CA, Siauve N, Pons JN, Poupon J, Clément O.
    Eur Radiol; 2005 Jul; 15(7):1369-77. PubMed ID: 15726379
    [Abstract] [Full Text] [Related]

  • 12. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.
    Simon GH, von Vopelius-Feldt J, Fu Y, Schlegel J, Pinotek G, Wendland MF, Chen MH, Daldrup-Link HE.
    Invest Radiol; 2006 Jan; 41(1):45-51. PubMed ID: 16355039
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters.
    Tanimoto A, Mukai M, Kuribayashi S.
    Magn Reson Med Sci; 2006 Jul; 5(2):89-98. PubMed ID: 17008765
    [Abstract] [Full Text] [Related]

  • 14. Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.
    Szerlip NJ, Walbridge S, Yang L, Morrison PF, Degen JW, Jarrell ST, Kouri J, Kerr PB, Kotin R, Oldfield EH, Lonser RR.
    J Neurosurg; 2007 Sep; 107(3):560-7. PubMed ID: 17886556
    [Abstract] [Full Text] [Related]

  • 15. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
    Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Gröne HJ, Misselwitz B, Semmler W, Kiessling F.
    Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
    [Abstract] [Full Text] [Related]

  • 16. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
    Herborn CU, Vogt FM, Lauenstein TC, Dirsch O, Corot C, Robert P, Ruehm SG.
    J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
    [Abstract] [Full Text] [Related]

  • 17. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
    Müller K, Skepper JN, Tang TY, Graves MJ, Patterson AJ, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH.
    Biomaterials; 2008 Jun; 29(17):2656-62. PubMed ID: 18377983
    [Abstract] [Full Text] [Related]

  • 18. Biodistribution of ultrasmall iron oxide particles in the rat liver.
    Van Beers BE, Sempoux C, Materne R, Delos M, Smith AM.
    J Magn Reson Imaging; 2001 Apr; 13(4):594-9. PubMed ID: 11276104
    [Abstract] [Full Text] [Related]

  • 19. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM, Seemayer C, Corot C, Gay RE, Goepfert K, Michel BA, Marincek B, Gay S, Weishaupt D.
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [Abstract] [Full Text] [Related]

  • 20. Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.
    Henning TD, Wendland MF, Golovko D, Sutton EJ, Sennino B, Malek F, Bauer JS, McDonald DM, Daldrup-Link H.
    Magn Reson Med; 2009 Aug; 62(2):325-32. PubMed ID: 19353670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.